The European Medicines Agency (EMA) has updated the agency's Brexit-related guidance documents on inspections and GMP certifications. These documents are to help support pharmaceutical companies in their preparations for the UK's withdrawal from the European Union. All medicinal products manufactured or imported into the Union (EEA) need to be manufactured in accordance with EU GMP (see also Commission Directive 2003/94/EC, Recital (1) and Commission Directive 1991/412/EEC).
展开▼
